Device Center Change May Cast Shadow On Woodcock's Future At CDER
This article was originally published in The Tan Sheet
Executive Summary
The pharmaceutical industry should weigh the resignation of Center for Devices and Radiological Health Director Dan Schultz in the context of what it means for their interactions with FDA's drug and biologics centers